http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220020578-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cbc74133c061218556539fd81f2a16f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ef8982a18411b5758f925376b15d6b5 |
| publicationDate | 2022-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20220020578-A |
| titleOfInvention | A composition for preventing and treating thrombosis diseases containing a artemisinin an active ingredient |
| abstract | The present invention relates to a composition for preventing and treating thrombotic diseases containing artemisinin as an active ingredient. By providing a composition containing artemisinin as an active ingredient, it is harmless to the human body and at the same time platelets are activated due to platelet activation. It relates to a composition that effectively inhibits aggregation and thrombogenesis, thereby preventing and treating various thrombotic diseases, such as arteriosclerosis, myocardial infarction, and stroke, caused by the platelet aggregation and thrombogenesis. |
| priorityDate | 2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.